论文部分内容阅读
[目的]观察参松养心胶囊治疗糖尿病心脏自主神经病变疗效。[方法]使用随机平行对照方法,将112例住院患者按随机数字表法随机分为两组。对照组56例参松养心胶囊,1.2g/次,3次/d,口服。常规治疗治疗同对照组。两组均连续治疗15d为1疗程。观测临床症状、HRV、不良反应。治疗1疗程,判定疗效。[结果]治疗组痊愈8例,显效33例,无效10例,总有效率80.40%。对照组痊愈6例,显效27例,无效19例,总有效率33.25%。治疗组疗效优于对照组(P<0.05)。[结论]参松养心胶囊治疗糖尿病心脏自主神经病变效果显著,值得推广。
[Objective] To observe the effect of Shensong Yangxin Capsule in the treatment of diabetic autonomic neuropathy. [Methods] Using randomized parallel control method, 112 inpatients were randomly divided into two groups according to random number table method. Control group, 56 cases of Shensong Yang Xin Capsule, 1.2g / time, 3 times / d, orally. Routine treatment with the control group. Both groups were treated for 15 days for a course of treatment. Observed clinical symptoms, HRV, adverse reactions. Treatment of a course of treatment to determine the efficacy. [Results] The treatment group cured in 8 cases, markedly effective in 33 cases, ineffective in 10 cases, the total effective rate was 80.40%. The control group cured 6 cases, markedly effective in 27 cases, ineffective in 19 cases, the total effective rate was 33.25%. The treatment group was better than the control group (P <0.05). [Conclusion] Shensongyangxin Capsule is effective in treating diabetic autonomic neuropathy and is worth promoting.